Sun Pharmaceutical Industries’ share price fell 3.5 per cent intraday on Monday, despite a 43 per cent on-year growth in consolidated net profit at Rs 2,061 crore in FY23. The company reported a profit of Rs 1,444 crore in the corresponding quarter of previous year. The stock has risen 18.7 per cent in one year, …
